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To the Editor: A 39-year-old man was undergoing hemo-
dialysis since 4 years for end-stage renal disease owing
to hypertension. He presented a recurrent skin rash at the
end of each hemodialysis session. The same symptoms,
that is, itchy wheals affecting predominantly the trunk
and the proximal parts of the limbs, spontaneously
disappearing after half an hour, occurred after physical
exercise, exposure to sun, and hot showers. Given these facts,
we considered hemodialysis-induced generalized cholinergic
heat urticaria.1
To our knowledge, only one case of hemodialysis-induced
cholinergic urticaria has been described.1 To confirm this
hypothesis, we performed a challenge test.1 When the
dialysate temperature was decreased from the regular 36.5
to 351C, the patient was symptom free during numerous
dialysis sessions. Urticarial lesions reappeared when the
temperature was raised from 35 to 37.51C in steps of 0.51C
and in intervals of 30 min, confirming the diagnosis.
Generalized cholinergic heat urticaria is a form of physical
urticaria with characteristic wheals of 1–5 mm diameter
caused by stimuli, which raise the core body temperature
such as physical exercise, hot baths, and emotional stress.2 It
is a common cause of urticaria (4–7%) and is often not
prevented by antihistamines. How hemodialysis induces a
raise in body temperature is not well understood. One
hypothesis is that volume depletion during dialysis provokes
a peripheral vasoconstriction leading to a reduced dissipation
of heat from the skin.3
Hemodialysis-induced generalized cholinergic heat urti-
caria is probably underdiagnosed. A simple adjustment of the
dialysis temperature will prevent the itchy lesions.
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To the Editor: Researchers increasingly investigate artificial
neural networks as a tool for individualized prediction in
clinical medicine. A recent article by Oates et al.1 in Kidney
International, concluded that an artificial neural network
could identify significant urinary protein spots for predicting
class and chronicity in patients with lupus nephritis.
However, only the discrimination statistic was used. Mea-
surement of the calibration statistic, a key step to evaluate the
goodness-of-fit reliability for neural networks was ignored.
Without both statistics, readers cannot recognize whether the
model is truly applicable.
Discrimination measures how well a model classifies
subjects correctly into different clusters. Calibration reflects
the degree of correspondence between estimated probabilities
of a model and actual observation. Sensitivity, specificity, and
area under the receiver operating characteristic curve are
usually used to quantify the power of discrimination. Good
discrimination only supports the use of these models for
stratification. This does not signify suitability for individual
cases because when classification outputs are transformed
monotonically, good discrimination can have the probability
of poor calibration.2 To avoid this pitfall, the misclassification
rate, Pearson’s w2, or Hosmer–Lemeshow statistic should be
used to measure calibration. Quality of classification models
must be assessed with respect to discrimination and
calibration concurrently.3
Any new model should be carefully appraised before
application. However, Dreiseitl et al.4 found that calibration
information was overlooked in 75% of investigations.
Improper assessments may lead to wrong decisions, thus
affecting therapeutic plans and outcomes for patients. We
therefore emphasize the significance of calculating discrimi-
nation and calibration simultaneously.
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The comment from Lin et al.1 raises a very interesting and
often neglected issue, that while looking for the biomarker
needle in the haystack of candidate molecules, characteri-
zation of the experimental signal is often neglected. In the
quest for classifiers of disease among multiple candidate
markers, which sometimes gets the derogatory description
of ‘fishing expedition’, the emphasis is narrowly placed on
discrimination. This is a pragmatic approach that is ideally
validated by comparing predictions and observations for
external data sets. As obviously important as this
validation seems, it has not been successfully done for
any identified set of plasma or urine protein biomarkers
discovered using proteomic techniques. Validation is hard
enough as the ‘blindness’ of external testing may be biased
by lack of independence between the training and testing
data sets.2 Therefore, in our opinion, the twin issues of
calibration and discrimination can be safely reported
separately as we did.3 The calibration methodology, which
relies on non-parametric normalization, is referenced in
the Methods section to an earlier report by us.4 We
nevertheless agree that this is not reason enough not to
explicitly document at least the reproducibility of the
signal to be used as a reference for the reproducibility
reported for the prediction. Before conceding this point a
few considerations are in order when comparing the two,
as calibration might muddy rather than clarify the issue of
predictability.
Predictability can be accessed simply and objectively by
comparing false and true positive classifications for the
range of decision threshold values. This exercise will
produce the well-established Receiver Operator Characteris-
tics curves5 used in our report. The main challenge there is
to do so with a truly independent external data set. On the
contrary, as regards the calibration of a multivariate signal,
one can only provide a straightforward answer as regards
the technical/methodological variability – for example, that
obtained by analyzing the same sample repeated times. The
biological variability is an entirely different matter, as the
predictive signal may rely not on the variation of
individual variables (candidate markers) but on the co-
variation of multiple markers (biomarker patterns). The
classical illustration of this point is the XOR (exclusive OR
signal). Let us imagine a variable that is observed with
unpredictable value in a population as regards being high
or low in the disease vs healthy subgroup. Now let us
imagine a second variable that is a function of the first and
it is the shape of this function that is distinct between the
disease and healthy subgroups. That would cause the
second variable to appear to be as unpredictive as the first
when analyzed individually, while a classifier could be
identified that used the relationship between the two to
accurately predict the disease state. Even in the case the
distribution of values in the general population changes
with time, for example owing to changes in life style, if the
predictive co-variation is rooted on physiological mechan-
isms, the predictive model could, in principle, remain
insensitive to those changes.
Our recent reporting on potential biomarkers for lupus
nephritis is based on a survey of urine proteins in only 20
patients in a single institution, definitely not a clinical
trial. As your correspondent rightly notes, quoting from
Matheny et al. where a 5216 patient data set was analyzed,6
blind reliance on our report to classify new patients is not
advisable not only because different laboratory practices
may introduce changes in measured values but also
because the populations themselves may be very distinct.
Similarly to that report, our identification of predictive
models also relied on resampled cross-validation (we
followed, and referenced, the guidelines for neural network
model identification we previously proposed7). In spite of
the shortcomings of the report (and the field in general),
the study achieved the goal of identifying candidate
markers that could be used for biopsy-free classification
of lupus nephritis. These markers can now be confirmed
using more reproducible and rapid assays to determine if
they hold up in larger sets of patients.
In a nutshell, we agree with the suggestion of Lin, Chiu
et al. as regards documentation of technical variability/
calibration when reporting accuracy in predictions based
on proposed markers. Nevertheless, for an audience with a
pragmatic interest in making predictions about disease
states, it appears that the litmus test should remain with
proving that it works for an external data set.
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